Brief: Fusion Pharmaceuticals Q1 Loss Per Share $0.46
10/05/2022 12:08
May 10 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* Q1 LOSS PER SHARE $0.46
* AS OF MARCH 31, 2022, FUSION HELD CASH, CASH EQUIVALENTS
AND
INVESTMENTS OF $206.7 MILLION
* Q1 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nCNW174ZRa
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary